MINNEAPOLIS (April 10, 2017) – On Thursday, April 13, OneOme’s director of medical affairs Josiah Allen will speak about the power of pharmacogenomics in personalized medicine at the Design of Medical Devices Conference Emerging Technology Forum. The event, which explores “Personalized Medical...
OneOme’s Director of Medical Affairs to Speak on Power of Pharmacogenomics at Design of Medical Devices Conference
Josiah Allen Speaking at Emerging Technology Forum on April 13th at 10:15 a.m.
04/10/2017
OneOme Shares Findings of Pharmacogenomics Awareness Survey
RightMed test mitigates barriers for implementing pharmacogenomics
03/27/2017
MINNEAPOLIS (March 27, 2017) – Pharmacogenomics company OneOme today announced the results of its clinician pharmacogenomic testing awareness survey. OneOme will formally share its findings at the Academy of Managed Care Pharmacy (AMCP) Managed Care & Specialty Pharmacy Annual Meeting, which begin...
Results from OneOme’s RightMed test now can be integrated into a patient’s Electronic Medical Record (EMR)
03/21/2017
MINNEAPOLIS (March 21, 2017) – OneOme continues to make strides to ensure its powerful pharmacogenomics testing is a lasting tool for patients and healthcare providers. Results from OneOme’s RightMed test, which analyzes an individual’s DNA to predict his or her response to medications, now ca...
Minnesota Monthly: How personalized medicine will make us healthier
03/20/2017
Minnesota Monthly published an article describing how precision medicine can help improve people’s health, highlighting OneOme as a company that strives to bring precision medicine into routine clinical care.
The article cites the example of a woman who suddenly fell so ill that she was hours...
OneOme Announces New Specimen Option to Further Bring Its Powerful Pharmacogenomic Test into Routine Clinical Care
03/13/2017
MINNEAPOLIS (March 13, 2017) – OneOme today announced that healthcare providers now are able to order OneOme’s RightMed® pharmacogenomic test as part of an ordinary blood panel. Previously, the RightMed test was only available through a cheek swab. Making testing available using blood will furt...
